Try our Advanced Search for more refined results
Private Equity
Private Equity Law360 provides breaking news and analysis on private equity deals and the attorneys involved. Coverage includes high-impact deals, related litigation and enforcement actions, and policy developments that affect private equity firms.
Sign up for a 7-day FREE trial today!
Latest News in Private Equity
-
January 30, 2026
Freshfields-Led Permira's Investment Values Carne At €1.4B
Carne Group said Friday that it has agreed to sell a "significant minority stake" to British global investment firm Permira in a deal that values the third-party management company at approximately €1.4 billion ($1.7 billion).
-
January 30, 2026
Warsh Clinches Trump's Nomination For Fed Chair
President Donald Trump is nominating former Federal Reserve Gov. Kevin Warsh to lead the central bank as its next chairman, elevating a critic of the Fed's leadership as the White House pushes against its traditional independence.
-
January 29, 2026
Trump SPAC Fights Chancery's $25K Daily Sanction Ruling
The blank check company that took Trump Media & Technology Group Corp. public last year says it has been "unfairly trapped in a procedural morass" after a Delaware Chancery Court magistrate held the company in contempt and ordered it to pay sanctions over its refusal to pay an over $2 million legal fee advancement bill.
-
January 29, 2026
Zuora Investor Sues Over $1.7B Silver Lake Take-Private Deal
An investor in software as service subscription software venture Zuora Inc. has opened a proposed class suit seeking damages in connection with Silver Lake Group's $1.7 billion take-private acquisition of the company, naming both Silver Lake and managing panther Joseph Osnoss and alleging breaches of fiduciary duty.
-
January 29, 2026
Inspire Medical Leaders Face Suit Over Apnea Device Rollout
Brass of Inspire Medical Systems Inc. face shareholder derivative claims they breached their fiduciary duties by concealing issues affecting the launch of the company's latest sleep apnea device, damaging investors after its trading prices fell 32% when the issues were disclosed.
Areas of Coverage
- TRANSACTIONS
- Private equity deals valued at $50MM or more
- Venture capital investments of $25MM or more
- Mergers and acquisitions
- Capital investments, including mezzanine and growth capital deals
- Joint ventures involving private equity firms
- Hostile takeovers and leveraged buyouts
- Distressed investment deals
- AGENCIES
- U.S. Commodity Futures Trading Commission
- Federal Trade Commission
- Financial Industry Regulatory Authority
- Public Company Accounting Oversight Board
- U.S. Department of Justice
- U.S. Department of the Treasury
- U.S. Securities and Exchange Commission
- International competition and securities regulators
- POLICY & REGULATION
- Dodd-Frank Act
- Delaware corporate law
- Antitrust and consumer protection controls
- Private equity industry lobbying
- International banking legislation and regulation
- ENFORCEMENT
- Merger reviews
- Second requests
- Challenges and divestitures
- Litigation
- Antitrust suits
- Shareholder disputes
- Corporate governance fights
- Poison pill challenges
- Hostile takeover disputes
- Privacy and consumer protection suits
- Bankruptcy proceedings involving private equity stakeholders
- PROFILES
- Personnel moves
- Profiles of private equity practices
Readership
- Private equity lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the private equity industry
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals